These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32606935)

  • 41. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
    Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
    Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status.
    Sørensen MD; Nielsen O; Reifenberger G; Kristensen BW
    Brain Pathol; 2021 May; 31(3):e12921. PubMed ID: 33244787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
    Zhou Q; Yan X; Liu W; Yin W; Xu H; Cheng D; Jiang X; Ren C
    Front Oncol; 2020; 10():586019. PubMed ID: 33425739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and Clinical Characterization of LIGHT/TNFSF14 Expression at Transcriptional Level
    Yang Y; Lv W; Xu S; Shi F; Shan A; Wang J
    Front Mol Biosci; 2021; 8():567327. PubMed ID: 34513918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 47. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
    Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.
    Miftah H; Naji O; Ssi SA; Ghouzlani A; Lakhdar A; Badou A
    Front Immunol; 2023; 14():1139268. PubMed ID: 37575237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value and Biological Function of Galectins in Malignant Glioma.
    Zhu H; Liu D; Cheng L; Liu J; Wang G; Li H; Zhang Y; Mi H; Zhang S; Shu K; Yu X
    Front Oncol; 2022; 12():834307. PubMed ID: 35814469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma.
    Xia QX; Yu J; Wang ZJ; Guan QW; Mao XY
    Front Pharmacol; 2022; 13():990461. PubMed ID: 36160460
    [No Abstract]   [Full Text] [Related]  

  • 52. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
    Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
    PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
    Ye N; Jiang N; Feng C; Wang F; Zhang H; Bai HX; Yang L; Su Y; Huang C; Wanggou S; Li X
    J Cancer; 2019; 10(22):5536-5548. PubMed ID: 31632497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
    Long S; Li M; Liu J; Yang Y; Li G
    Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
    Ji X; Ding F; Gao J; Huang X; Liu W; Wang Y; Liu Q; Xin T
    Front Oncol; 2020; 10():573800. PubMed ID: 33194678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.
    Szeliga M
    Neurochem Int; 2022 Feb; 153():105256. PubMed ID: 34968631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer.
    Zhang Y; Li L; Ke XP; Liu P
    Transl Cancer Res; 2023 Dec; 12(12):3409-3424. PubMed ID: 38192993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.
    Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal N; Kota V; Rojiani MV; Rojiani AM; Kolhe R
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33466402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways.
    Wang Z; Zhang J; Zhang H; Dai Z; Liang X; Li S; Peng R; Zhang X; Liu F; Liu Z; Yang K; Cheng Q
    Front Cell Dev Biol; 2022; 10():740822. PubMed ID: 35252165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.